Accreditation Information

Criteria for Success: There is no fee to participate in this activity. Statements of credit will be awarded based on the participant's attendance.  A statement of credit will be available upon completion of an online evaluation/claim credit form

36^th Annual Conference of the MI ACC

September 21 – 22, 2024 | Acme, Michigan

Activity Overview

This activity offers a unique opportunity to network with fellow cardiology professionals from across the state while exploring the
latest advancements in cardiovascular medicine.

akhcme.com/miacc 

Please claim your credit by October 15, 2024.

If you have questions about this CE activity, please contact AKH Inc at [email protected].

Target Audience

This activity is designed for an audience of physicians, physician associates, nurse practitioners, pharmacists and nurses.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

• Describe the symptomatology, etiology and pathophysiology of tricuspid regurgitation.
• Outline the indications for percutaneous tricuspid valve intervention and optimal selection criteria.
• Gain an in-depth understanding of the transcatheter treatment options and device selection.
• Recognize the significance of imaging in TAVR procedures.
• Identify the utility of different imaging modalities in the pre-, intra-, and post-procedure stages.
• Discuss the benefits of imaging in guiding clinical decisions and care of TAVR patients.
• Identify appropriate indications and patient selection for Cardiac CTA.
• Review the anatomic and physiologic information available from Cardiac CTA and CTFFR.
• Discuss the prognostic information available from coronary calcium and coronary plaque data available with Cardiac CT.
• Recognize clinical implications of Advanced Cardiovascular Imaging and diagnostic algorithms in identification of cardiac tumors and thrombi.
• Recognize the importance of Cardiac Imaging in management and follow up of patients with cardiac masses.
• Identify key selection criteria for cardiac transplantation.
• Explore survival benefits of cardiac transplantation.
• Review recent advancements in transplantation technology that expand the donor pool and improve clinical outcomes.
• Specify which treatment options are available for treatment of advanced heart failure in 2024 and their associated outcomes.
• Generalize the temporary support devices under study aimed at treating cardiorenal syndrome.
• Assess which factors may limit early referral for durable LVAD therapy for patients with advanced HFrEF within your practice.
• Identify when to escalate treatment of cardiogenic shock (CS) to temporary mechanical circulatory support (MCS).
• Differentiate benefits and alternatives of different temporary MCS devices in the treatment of CS.
• Identify modifiable risk factors that promote atrial fibrillation.
• Recognize the benefit of early rhythm control in managing AF.
• Discuss new technology for atrial fibrillation ablation.
• Determine overall risks and complications and AF ablations.
• Review types of EP procedures are being performed at hospitals without onsite surgery and at ambulatory surgical centers.
• Discuss safety of performance of AF ablations at hospitals without onsite surgery or at ambulatory surgical centers.
• Define artificial intelligence.
• Identify unique opportunities and challenges of AI in atrial fibrillation care, both in research and in day-to-day patient care.
• Describe ways wearable data and clinic workflows may be modified to integrate AI in outpatient atrial fibrillation care.
• Explain recent advances in AI applications in Echocardiography.
• Select appropriate testing and imaging modality.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

Joint Accreditation Statement:

In support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Michigan Chapter, American College of Cardiology. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses

Credit being awarded: 8.5 ANCC contact hours

Pharmacists

AKH Inc., Advancing Knowledge in Healthcare designates this continuing education activity for 8.5 contact hours.

Physician Assistant

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 8.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse Practitioners
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Michigan Chapter, American College of Cardiology.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 8.5 contact hour(s) (which includes 6.0 hour(s) of pharmacology).

Criteria for Success

Certificates of completion will be awarded based on the participant's attendance.  A certificate of completion will be available upon completion of an online evaluation/claim credit form available at:

Commercial Support

There is no commercial support for this activity.

Disclosures

It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with ineligible companies whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are mitigated by AKH prior to accreditation of the activity. AKH planners and reviewers have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use and Investigational Product

This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participants misunderstanding of the content.

If you would like to opt out from future communications from AKH please send an email to [email protected] with your information with "Opt Out" in the subject line.